Diabetes Mellitus, and Not Obesity, Is Associated with Lower Survival Following Liver Transplantation

Digestive Diseases and Sciences

Volumn 60, Issue 4, 2015, Pages 1036-1044

  Wong, Robert J ^a,f   Cheung, Ramsey ^b,c   Perumpail, Ryan B ^b,e   Holt, Edward W ^d   Ahmed, Aijaz ^b,e  

^a Alameda Health System   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Body mass index; Diabetes; Metabolic syndrome; UNOS

Indexed keywords

ADULT; AGED; COMPLICATION; DIABETES MELLITUS; EPIDEMIOLOGY; FEMALE; HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; OBESITY; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; DIABETES COMPLICATIONS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84934289580     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3469-8     Document Type: Article

References (39)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311:806–814.
2. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677–685.
3. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097–1105.
4. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on US life expectancy. N Engl J Med. 2009;361:2252–2260.
5. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689.
6. Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–1209.
7. Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obesity. 2000;8:605–619.
8. Jiang J, Torok N. Nonalcoholic steatohepatitis and the metabolic syndrome. Metab Syndr Relat Disord. 2008;6:1–7.
9. Thuluvath PJ, Yoo HY, Thompson RE. A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl. 2003;9:527–532.
10. Thuluvath PJ. Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation. Liver Transpl. 2007;13:1627–1629.
11. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249–1253.
12. Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the US. Hepatology. 2014;59:2188–2195.
13. Agopian VG, Kaldas FM, Hong JC, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256:624–633.
14. Singal AK, Guturu P, Hmoud B, et al. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013;95:755–760.
15. Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35:105–109.
16. Zaydfudim V, Feurer ID, Moore DE, et al. The negative effect of pretransplant overweight and obesity on the rate of improvement in physical quality of life after liver transplantation. Surgery. 2009;146:174–180.
17. Pelletier SJ, Schaubel DE, Wei G, et al. Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl. 2007;13:1678–1683.
18. Saab S, Lalezari D, Pruthi P, Alper T, Tong MJ. The impact of obesity on patient survival in liver transplant recipients: a meta-analysis. Liver Int. 2015;35:164–170.
19. Choban PS, Flancbaum L. The impact of obesity on surgical outcomes: a review. J Am Coll Surg. 1997;185:593–603.
20. Flancbaum L, Choban PS. Surgical implications of obesity. Annu Rev Med. 1998;49:215–234.
21. Keeffe EB, Gettys C, Esquivel CO. Liver transplantation in patients with severe obesity. Transplantation. 1994;57:309–311.
22. Nair S, Cohen DB, Cohen MP, Tan H, Maley W, Thuluvath PJ. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol. 2001;96:842–845.
23. Hillingsø JG, Wettergren A, Hyoudo M, Kirkegaard P. Obesity increases mortality in liver transplantation–the Danish experience. Transpl Int. 2005;18:1231–1235.
24. Pelletier SJ, Schaubel DE, Wei G, et al. Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl. 2007;13:1678–1683.
25. Orci LA, Majno PE, Berney T, Morel P, Mentha G, et al. The impact of wait list body mass index changes on the outcome after liver transplantation. Transpl Int. 2013;26:170–176.
26. Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant. 2008;8:667–672.
27. Dick AA, Spitzer AL, Seifert CF, et al. Liver transplantation at the extremes of the body mass index. Liver Transpl. 2009;15:968–977.
28. LaMattina JC, Foley DP, Fernandez LA, et al. Complications associated with liver transplantation in the obese recipient. Clin Transplant. 2012;26:910–918.
29. Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology. 2012;56:1741–1750.
30. Hakeem AR, Cockbain AJ, Raza SS, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl. 2013;19:551–562.
31. Tanaka T, Renner EL, Selzner N, Therapondos G, Lilly LB. The impact of obesity as determined by modified body mass index on long-term outcome after liver transplantation: Canadian single-center experience. Transplant Proc. 2013;45:2288–2294.
32. Perez-Protto SE, Quintini C, Reynolds LF, et al. Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl. 2013;19:907–915.
33. Dare AJ, Plank LD, Phillips AR, et al. The additive effect of pre-transplant obesity, diabetes and cardiovascular risk factors on outcome after liver transplantation. Liver Transpl. 2014;20:281–290.
34. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002;73:70–74.
35. Jindal RM, Zawada ET Jr. Obesity and kidney transplantation. Am J Kidney Dis. 2004;43:943–952.
36. Heuer M, Kaiser GM, Kahraman A, et al. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. Digestion. 2012;86:107–113.
37. Ertle J, Dechêne A, Sowa JP, et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer. 2011;128:2436–2443.
38. Perseghin G, Mazzaferro V, Sereni LP, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology. 2000;31:694–703.
39. Wallia A, Parikh ND, Molitch ME, et al. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation. 2010;89:222–226.